Advertisement

Topics

TARIS Biomedical LLC and Uppsala Clinical Research Center Company Profile

21:06 EDT 14th August 2018 | BioPortfolio

UCR’s mission is to improve human health in Sweden and worldwide. UCR has the competence and technology necessary to transform innovative ideas into translational research projects, clinical studies, and registry-based improvement projects. UCR is organized as an independent, non-profit research center affiliated with Uppsala University and Uppsala University Hospital.www.ucr.uu.se


News Articles [2741 Associated News Articles listed on BioPortfolio]

TARIS® Announces Research Collaboration Focused on Natural History of Muscle Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy

Collaboration with Uppsala Clinical Research Center and Professor Per-Uno Malmström TARIS Biomedical LLC announced today that it has engaged in a research colla...

TARIS ® to Present at Cowen Health Care Conference

TARIS announced that CEO Purnanand Sarma is presenting today, March 12th, at the Cowen and Company 38th Annual Health Care Conference from 8:30-8:55 a.m. ET in the Northeas...

U.S. FDA Grants Fast Track Designation to TARIS® for TAR-200 (GemRIS™) in Muscle Invasive Bladder Cancer

Designation for Patients Unfit for Curative Intent Therapy TARIS today announced that the United States Food and Drug Administration (FDA) has granted Fast Track design...

Taris Biomedical LLC Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

Taris Biomedical LLC Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Taris Biomedical LLC Mergers Acquisitions MA, Partnerships Alliances and Investments ...

TARIS® Initiates Dosing of TAR-200 (GemRIS™) in Muscle-Invasive Bladder Cancer Patients Unfit for Curative Intent Therapy

TARIS announced today that it has initiated dosing in a clinical trial of TAR-200 (GemRIS™) in patients with Muscle Invasive Bladder Cancer (MIBC) who are unfit for thera...

TARIS® Announces Late-Breaking Poster Presentation at American Association of Cancer Research Annual Meeting

TARIS today announced that it will present a late-breaking poster related to TAR-200 (GemRIS™), the company’s lead clinical program in bladder cancer, at the upcoming A...

LSU Pennington Biomedical Research Center approved for $4.5M childhood obesity treatment study

(Louisiana State University) A research team at LSU's Pennington Biomedical Research Center has been approved for a five-year, $4.5 million funding award by the Patient-Centered Outcomes Research Inst...

Mount Sinai Opens Center for Biomedical Blockchain Research to Develop Healthcare Blockchain Apps

First venture launched by an academic medical center to use blockchain technology to solve healthcare and medical science problems. The Icahn School of Medicine at Mount Sinai and the Institute for Ne...

PubMed Articles [5940 Associated PubMed Articles listed on BioPortfolio]

Misrepresentation of the Pennington Biomedical Research Center Weight Loss Predictor.

POPCORN: A web service for individual PrognOsis Prediction based on multi-center clinical data CollabORatioN without patient-level data sharing.

Clinical prognosis prediction plays an important role in clinical research and practice. The construction of prediction models based on electronic health record data has recently become a research foc...

Applying participatory action research in traumatic brain injury studies to prevent post-traumatic epilepsy.

The increased focus on stakeholder engagement in determining the aims, design, conduct of research and dissemination of results is substantially changing the biomedical research paradigm. In this era ...

Regenerative Medicine Strategies in Biomedical Implants.

Recently, significant progress has been made in the research related to regenerative medicine. At the same time, biomedical implants in orthopedics and dentistry are facing many challenges and posing ...

Exploiting Semantic Patterns over Biomedical Knowledge Graphs for Predicting Treatment and Causative Relations.

Identifying new potential treatment options for medical conditions that cause human disease burden is a central task of biomedical research. Since all candidate drugs cannot be tested with animal and ...

Clinical Trials [5458 Associated Clinical Trials listed on BioPortfolio]

Safety and Tolerability Study of the Taris Placebo System

The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

More than 10 million Americans have chronic kidney disease and every year, approximately 100,000 new patients develop end stage renal disease (ESRD) resulting in incalculable human sufferi...

Companies [5212 Associated Companies listed on BioPortfolio]

TARIS Biomedical LLC and Uppsala Clinical Research Center

UCR’s mission is to improve human health in Sweden and worldwide. UCR has the competence and technology necessary to transform innovative ideas into translational research pr...

TARIS Biomedical LLC

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new treatments for millions of patients suffering from difficult-to-treat ...

Bristol-Myers Squibb and TARIS Biomedical LLC

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new therapies for millions of patients suffering from difficult-to-treat ...

TARIS Biomedical

TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device converge...

Uppsala Science Park KB

Uppsala Science Park is located in the centre of the campus that contains Uppsala's two universities, which together consist of 200 research and educational departments. There are about 150 companie...

More Information about "TARIS Biomedical LLC and Uppsala Clinical Research Center" on BioPortfolio

We have published hundreds of TARIS Biomedical LLC and Uppsala Clinical Research Center news stories on BioPortfolio along with dozens of TARIS Biomedical LLC and Uppsala Clinical Research Center Clinical Trials and PubMed Articles about TARIS Biomedical LLC and Uppsala Clinical Research Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TARIS Biomedical LLC and Uppsala Clinical Research Center Companies in our database. You can also find out about relevant TARIS Biomedical LLC and Uppsala Clinical Research Center Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record